Guy Wendy 4

What Happened
Wendy Guy, Chief Administrative Officer of Processa Pharmaceuticals (PCSA), made an open-market purchase of 1,829 shares on May 29, 2026 at $2.57 per share, for a total outlay of $4,701. This transaction is a purchase (insider buying is often viewed as more informative than routine selling).

Key Details

• Transaction date: 2026-05-29
• Transaction type/code: Open-market purchase (Code P)
• Price per share: $2.57; Shares acquired: 1,829; Total value: $4,701
• Form 4 filed: 2026-06-01 (Period of Report: 2026-05-29) — filing appears timely (within required business-day window)
• Shares owned after transaction: Not specified in the provided filing excerpt
• Footnotes/plan: No 10b5-1 plan, tax withholding, or other special footnotes indicated in the provided data

Context
The purchase size is modest ($4.7k), so while it is a direct insider buy, it’s small in dollar terms. The filing contains no additional explanatory notes, so no inference about motivation should be drawn beyond the reported facts.